These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 22984594)
1. Clues to occult cancer in patients with ischemic stroke. Kim SJ; Park JH; Lee MJ; Park YG; Ahn MJ; Bang OY PLoS One; 2012; 7(9):e44959. PubMed ID: 22984594 [TBL] [Abstract][Full Text] [Related]
2. Ability of the number of territories involved on DWI-MRI to predict occult systemic malignancy in cryptogenic stroke patients. Guo L; Wang L; Liu W J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104823. PubMed ID: 32362555 [TBL] [Abstract][Full Text] [Related]
3. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients. Wang JY; Zhang GJ; Zhuo SX; Wang K; Hu XP; Zhang H; Qu LD Neurol Res; 2018 Nov; 40(11):948-954. PubMed ID: 30317943 [TBL] [Abstract][Full Text] [Related]
4. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke. Gon Y; Sakaguchi M; Takasugi J; Kawano T; Kanki H; Watanabe A; Oyama N; Terasaki Y; Sasaki T; Mochizuki H Eur J Neurol; 2017 Mar; 24(3):503-508. PubMed ID: 28026909 [TBL] [Abstract][Full Text] [Related]
5. Voxel-Based Lesion Mapping of Cryptogenic Stroke in Patients with Advanced Cancer: A Detailed Magnetic Resonance Imaging Analysis of Distribution Pattern. Achiha T; Takagaki M; Oe H; Sakai M; Matsui H; Nakanishi K; Ozaki T; Fujimoto Y; Yoshimine T; Nakanishi K; Kinoshita M J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1521-1527. PubMed ID: 28363514 [TBL] [Abstract][Full Text] [Related]
6. D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer. Nam KW; Kim CK; Kim TJ; An SJ; Demchuk AM; Kim Y; Jung S; Han MK; Ko SB; Yoon BW Eur J Neurol; 2017 Jan; 24(1):205-211. PubMed ID: 27766716 [TBL] [Abstract][Full Text] [Related]
7. D-dimer and Body CT to Identify Occult Malignancy in Acute Ischemic Stroke. Rosenberg J; Do D; Cucchiara B; Messé SR J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105366. PubMed ID: 33039769 [TBL] [Abstract][Full Text] [Related]
8. D-dimer and C-reactive Protein as Potential Biomarkers for Diagnosis of Trousseau's Syndrome in Patients with Cerebral Embolism. Tsushima M; Metoki N; Hagii J; Saito S; Shiroto H; Yasujima M; Kato T; Kudo N; Toyama Y; Yokono Y; Nozaka M; Kawamura Y; Nakata M; Tomita H J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104534. PubMed ID: 31810721 [TBL] [Abstract][Full Text] [Related]
9. Ischemic stroke in patients with cancer: is it different from usual strokes? Lee EJ; Nah HW; Kwon JY; Kang DW; Kwon SU; Kim JS Int J Stroke; 2014 Jun; 9(4):406-12. PubMed ID: 23981525 [TBL] [Abstract][Full Text] [Related]
10. Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke. Yamaguchi I; Kanematsu Y; Shimada K; Korai M; Miyamoto T; Shikata E; Yamaguchi T; Yamamoto N; Yamamoto Y; Kitazato KT; Okayama Y; Takagi Y Cerebrovasc Dis Extra; 2019; 9(3):129-138. PubMed ID: 31760390 [TBL] [Abstract][Full Text] [Related]
11. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Kim SG; Hong JM; Kim HY; Lee J; Chung PW; Park KY; Kim GM; Lee KH; Chung CS; Bang OY Stroke; 2010 Apr; 41(4):798-801. PubMed ID: 20150545 [TBL] [Abstract][Full Text] [Related]
12. DWI Lesion Patterns in Cancer-Related Stroke--Specifying the Phenotype. Schwarzbach CJ; Fatar M; Eisele P; Ebert AD; Hennerici MG; Szabo K Cerebrovasc Dis Extra; 2015; 5(3):139-45. PubMed ID: 26648971 [TBL] [Abstract][Full Text] [Related]
13. D-dimer levels and cerebral infarction in critically ill cancer patients. Ryu JA; Bang OY; Lee GH BMC Cancer; 2017 Aug; 17(1):591. PubMed ID: 28854911 [TBL] [Abstract][Full Text] [Related]
14. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer. Kono T; Ohtsuki T; Hosomi N; Takeda I; Aoki S; Sueda Y; Ishihara K; Nakamura T; Yamawaki T; Matsumoto M Geriatr Gerontol Int; 2012 Jul; 12(3):468-74. PubMed ID: 22233138 [TBL] [Abstract][Full Text] [Related]
15. MR-imaging pattern is not a predictor of occult atrial fibrillation in patients with cryptogenic stroke. Vollmuth C; Stoesser S; Neugebauer H; Hansel A; Dreyhaupt J; Ludolph AC; Kassubek J; Althaus K J Neurol; 2019 Dec; 266(12):3058-3064. PubMed ID: 31511980 [TBL] [Abstract][Full Text] [Related]
16. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale. Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249 [TBL] [Abstract][Full Text] [Related]
17. Multiple Infarcts Are Associated With Long-Term Stroke Recurrence and All-Cause Mortality in Cryptogenic Stroke Patients. Nezu T; Mukai T; Uemura J; Yamashita M; Kitano T; Wada Y; Yagita Y Stroke; 2016 Sep; 47(9):2209-15. PubMed ID: 27462116 [TBL] [Abstract][Full Text] [Related]
18. Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke. Nam KW; Kim CK; Kim TJ; An SJ; Oh K; Mo H; Kang MK; Han MK; Demchuk AM; Ko SB; Yoon BW PLoS One; 2017; 12(3):e0172793. PubMed ID: 28282388 [TBL] [Abstract][Full Text] [Related]
19. Association of ischemic lesion patterns on early diffusion-weighted imaging with TOAST stroke subtypes. Kang DW; Chalela JA; Ezzeddine MA; Warach S Arch Neurol; 2003 Dec; 60(12):1730-4. PubMed ID: 14676047 [TBL] [Abstract][Full Text] [Related]
20. D-dimer and diffusion-weighted imaging pattern as two diagnostic indicators for cancer-related stroke: A case-control study based on the STROBE guidelines. Shen Y; Li Y; Chen C; Wang W; Li T Medicine (Baltimore); 2020 Jan; 99(4):e18779. PubMed ID: 31977868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]